Spots Global Cancer Trial Database for recurrent vaginal cancer
Every month we try and update this database with for recurrent vaginal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | NCT00287885 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer | docetaxel | 18 Years - | Masonic Cancer Center, University of Minnesota | |
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00082823 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer | NCT01313104 | Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... | colposcopy cervical Papani... screening metho... screening metho... | 18 Years - | Northwestern University | |
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | NCT00118300 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer | capecitabine brachytherapy radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies | NCT00335998 | Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIA Vulv... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIB Vulv... Stage IIIC Ovar... Stage IIIC Vulv... Stage IV Ovaria... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... | triapine laboratory biom... external beam r... brachytherapy cisplatin pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer | NCT01313104 | Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... | colposcopy cervical Papani... screening metho... screening metho... | 18 Years - | Northwestern University | |
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer | NCT00941070 | Recurrent Cervi... Recurrent Vagin... Stage IB Cervic... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Therapy-related... | triapine cisplatin external beam r... quality-of-life... questionnaire a... fludeoxyglucose... positron emissi... computed tomogr... | 18 Years - | National Cancer Institute (NCI) | |
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer | NCT01764789 | Anxiety Disorde... Depression Fatigue Leydig Cell Tum... Ovarian Sarcoma Ovarian Stromal... Pain Peritoneal Carc... Pseudomyxoma Pe... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Gesta... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... | questionnaire a... quality-of-life... psychosocial as... behavioral inte... cognitive inter... educational int... | 21 Years - 85 Years | Ohio State University Comprehensive Cancer Center | |
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics | |
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer | NCT00005941 | Cervical Cancer Vaginal Cancer | therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | - 64 Years | Fred Hutchinson Cancer Center | |
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer | NCT03277482 | Recurrent Gynec... Metastatic Cerv... Metastatic Ovar... Metastatic Vagi... Metastatic Vulv... Metastatic Endo... Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Recurrent Endom... | Durvalumab Tremelimumab Radiation Thera... | 18 Years - | Dana-Farber Cancer Institute | |
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00083213 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer | NCT01313104 | Cervical Intrae... Cervical Intrae... Cervical Intrae... Recurrent Cervi... Recurrent Vagin... Recurrent Vulva... Stage 0 Cervica... Stage 0 Vaginal... Stage 0 Vulvar ... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IB Cervic... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage III Vulva... Stage IV Vulvar... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... | colposcopy cervical Papani... screening metho... screening metho... | 18 Years - | Northwestern University | |
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | NCT00545792 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer Carcinoma of th... | Avastin | 18 Years - | Dana-Farber Cancer Institute | |
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer | NCT00002562 | Cervical Cancer Vaginal Cancer | paclitaxel | - | National Cancer Institute (NCI) | |
Gene Therapy in Treating Patients With Cancer | NCT00004178 | Cancer | therapeutic aut... | 18 Years - | Roger Williams Medical Center | |
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | NCT00545792 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer Carcinoma of th... | Avastin | 18 Years - | Dana-Farber Cancer Institute | |
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer | NCT01764789 | Anxiety Disorde... Depression Fatigue Leydig Cell Tum... Ovarian Sarcoma Ovarian Stromal... Pain Peritoneal Carc... Pseudomyxoma Pe... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Gesta... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... | questionnaire a... quality-of-life... psychosocial as... behavioral inte... cognitive inter... educational int... | 21 Years - 85 Years | Ohio State University Comprehensive Cancer Center | |
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | NCT00066404 | Cancer | recombinant ade... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer | NCT01652794 | Leydig Cell Tum... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Cervi... Recurrent Endom... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Recurrent Vagin... Recurrent Vulva... | stereotactic bo... carboplatin gemcitabine hyd... laboratory biom... pharmacogenomic... | 19 Years - | Case Comprehensive Cancer Center | |
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00082823 | Cancer | ziv-aflibercept | 18 Years - 120 Years | Regeneron Pharmaceuticals | |
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery | NCT00842452 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | topotecan hydro... pharmacological... | 18 Years - | Case Comprehensive Cancer Center | |
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics |